Antibody-mediated prevention and treatment of HIV-1 infection

Novel broadly neutralizing antibodies targeting HIV-1 hold promise for their use in the prevention and treatment of HIV-1 infection. Pre-clinical results have encouraged the evaluation of these antibodies in healthy and HIV-1-infected humans. In first clinical trials, highly potent broadly neutraliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruell, Henning, Klein, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240265/
https://www.ncbi.nlm.nih.gov/pubmed/30445968
http://dx.doi.org/10.1186/s12977-018-0455-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240265/
https://www.ncbi.nlm.nih.gov/pubmed/30445968
http://dx.doi.org/10.1186/s12977-018-0455-9

Ejemplares similares